[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338280-105":59,"doc-detail-338280-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","newcastle-disease-virus-enhances-the-antitumor-efficacy-of-doxorubicin-in-a-cervical-cancer-mouse-model-research-open-access","Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model - Research Open Access","","Study evaluates Newcastle disease virus (NDV) as an oncolytic virus strategy to strengthen the antitumor effect of Doxorubicin (Doxo) in a mouse model of cervical cancer. TC1 cells were injected into C57BL/6 female mice, then animals received NDV, Doxo, or the combination, with PBS as control. Combined therapy improved survival and slowed tumor progression, increased nitric oxide and lactate dehydrogenase in splenocyte cultures, and boosted TNF-α, IL-12, and IFN-γ while reducing TGF-β and IL-4. Results support NDV as an adjunct to chemotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/newcastle-disease-virus-enhances-the-antitumor-efficacy-of-doxorubicin-in-a-cervical-cancer-mouse-model-research-open-access/338280/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/newcastle-disease-virus-enhances-the-antitumor-efficacy-of-doxorubicin-in-a-cervical-cancer-mouse-model-research-open-access/338280.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study?","Question",{"text":112,"@type":113},"To assess the therapeutic potential of Newcastle disease virus (NDV) in enhancing the antitumor efficacy of Doxorubicin (Doxo) in mouse models of cervical cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the treatment groups designed in the mouse model?",{"text":117,"@type":113},"TC1 cells were used to induce tumors in C57BL/6 mice, then mice were assigned to groups treated with NDV, Doxo, the combination of both, or PBS as control.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes improved with the combination treatment?",{"text":121,"@type":113},"The combined treatment produced significantly improved survival and slower tumor progression, and it increased nitric oxide and lactate dehydrogenase in splenocyte cultures while enhancing TNF-α, IL-12, and IFN-γ and reducing TGF-β and IL-4.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338280,1790457687,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Rasekhi Kazeruni etal. BMC Cancer (2024) 24:1253 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-13011-0](https://doi.org/10.1186/s12885-024-13011-0)  \nRESEARCH Open Access  \nNewcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model  \nAezam Rasekhi Kazeruni 1, Nahid Babaei 1*†, Hadi Esmaeili Gouvarchin Ghaleh 2*†, Abbas Doosti3 and Mahdieh Farzanehpour2  \nAbstract  \nBackground and aims Cervical cancer (CC) is a common cancer among women, often treated with Doxorubicin (Doxo) . Research is underway to explore the use of oncolytic virus (OV) therapy as a means to improve drug efficacy and enhance the immune system’s tumor-fighting capabilities. Hence, our study purposes to evaluate the therapeutic potential of Newcastle disease virus (NDV) in increasing the antitumor efficacy of Doxo in mouse models of CC. Methods and materials TC1 cells were administered to C57BL/6 mice (Female) in a range of 6 to 8 weeks age  \n(n = 40) to induce tumor growth. After tumor development, four treatment groups of mice were formed. Treatment were performed through NDV, Doxo, and a combination of both in three groups of treatment twice in a one-week intervention manner, while the control group treated with PBS. Following the last treatment, half of these mice were subjected to euthanize due to the immune-response assessment, and the other half were followed up till they died naturally in a certain period of time.  \nResults Mice that underwent the combined treatment showed significantly improved survival rates and slower tumor progression in comparison with the control group. This combined treatment substantially elevated nitric oxide (NO) and lactate dehydrogenase (LDH) levels in the splenocytes cultures of mice bearing cervical tumors. Furthermore, combination therapy resulted in a notable elevation inTNF-α, IL-12, and IFN-γ, secretion alongside a reduction in the release ofTGF-β and IL-4 within the splenocytes in counter with the treatment of just NDV or Doxo. Conclusion According to the findings ofthis study, it seems that utilizing NDV can improve the effectiveness of Doxo in a mouse model of CC, suggesting it can serve as an adjunct therapy alongside chemotherapy.  \nKeywords Newcastle Disease virus, Cervical cancer, Oncolytic virus, Doxorubicin, TC1 cell line  \n†Nahid Babaei and Hadi Esmaeili Gouvarchin Ghaleh equally contributed to this study.  \n*Correspondence:  \nNahid Babaei [Nahid.babaei@yahoo.com](Nahid.babaei@yahoo.com)[ ](Nahid.babaei@yahoo.com)Hadi Esmaeili Gouvarchin Ghaleh [H.smaili69@yahoo.com](H.smaili69@yahoo.com)  \n1Department of Molecular Cell Biology and Genetics, Bushehr Branch, Islamic Azad University, Bushehr, Iran  \n2Applied Virology Research Center, Biomedicine Technologies Institute, Baqiyatallah University of Medical sciences, Tehran, Iran 3Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/l](creativecommons.","cbCaigpDbNhvoGkl","https://ap.wps.com/l/cbCaigpDbNhvoGkl","pdf",1455420,"English","# Abstract\n## Background and aims\n## Methods and materials\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main purpose of the study?\",\"answer\":\"To assess the therapeutic potential of Newcastle disease virus (NDV) in enhancing the antitumor efficacy of Doxorubicin (Doxo) in mouse models of cervical cancer.\"},{\"question\":\"How were the treatment groups designed in the mouse model?\",\"answer\":\"TC1 cells were used to induce tumors in C57BL/6 mice, then mice were assigned to groups treated with NDV, Doxo, the combination of both, or PBS as control.\"},{\"question\":\"What outcomes improved with the combination treatment?\",\"answer\":\"The combined treatment produced significantly improved survival and slower tumor progression, and it increased nitric oxide and lactate dehydrogenase in splenocyte cultures while enhancing TNF-α, IL-12, and IFN-γ and reducing TGF-β and IL-4.\"}]","Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model - Research Open Access | PDF",1790022903,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/015230db8d3019f190282485bbe0eef7.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a88101190235029b039d0bf09ee83599.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33ac78e35e1375e51a6db3e5c8d8fa5d.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d17205ee37b4f2f09ba286fd50d46e9e.webp",980,1306]